1
|
Comanducci A, Boly M, Claassen J, De Lucia M, Gibson RM, Juan E, Laureys S, Naccache L, Owen AM, Rosanova M, Rossetti AO, Schnakers C, Sitt JD, Schiff ND, Massimini M. Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: review of an IFCN-endorsed expert group. Clin Neurophysiol 2020; 131:2736-2765. [PMID: 32917521 DOI: 10.1016/j.clinph.2020.07.015] [Citation(s) in RCA: 91] [Impact Index Per Article: 22.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 07/06/2020] [Accepted: 07/26/2020] [Indexed: 12/13/2022]
Abstract
The analysis of spontaneous EEG activity and evoked potentialsis a cornerstone of the instrumental evaluation of patients with disorders of consciousness (DoC). Thepast few years have witnessed an unprecedented surge in EEG-related research applied to the prediction and detection of recovery of consciousness after severe brain injury,opening up the prospect that new concepts and tools may be available at the bedside. This paper provides a comprehensive, critical overview of bothconsolidated and investigational electrophysiological techniquesfor the prognostic and diagnostic assessment of DoC.We describe conventional clinical EEG approaches, then focus on evoked and event-related potentials, and finally we analyze the potential of novel research findings. In doing so, we (i) draw a distinction between acute, prolonged and chronic phases of DoC, (ii) attempt to relate both clinical and research findings to the underlying neuronal processes and (iii) discuss technical and conceptual caveats.The primary aim of this narrative review is to bridge the gap between standard and emerging electrophysiological measures for the detection and prediction of recovery of consciousness. The ultimate scope is to provide a reference and common ground for academic researchers active in the field of neurophysiology and clinicians engaged in intensive care unit and rehabilitation.
Collapse
Affiliation(s)
- A Comanducci
- IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy
| | - M Boly
- Department of Neurology and Department of Psychiatry, University of Wisconsin, Madison, USA; Wisconsin Institute for Sleep and Consciousness, Department of Psychiatry, University of Wisconsin-Madison, Madison, USA
| | - J Claassen
- Department of Neurology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, USA
| | - M De Lucia
- Laboratoire de Recherche en Neuroimagerie, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - R M Gibson
- The Brain and Mind Institute and the Department of Physiology and Pharmacology, Western Interdisciplinary Research Building, N6A 5B7 University of Western Ontario, London, Ontario, Canada
| | - E Juan
- Wisconsin Institute for Sleep and Consciousness, Department of Psychiatry, University of Wisconsin-Madison, Madison, USA; Amsterdam Brain and Cognition, Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands
| | - S Laureys
- Coma Science Group, Centre du Cerveau, GIGA-Consciousness, University and University Hospital of Liège, 4000 Liège, Belgium; Fondazione Europea per la Ricerca Biomedica Onlus, Milan 20063, Italy
| | - L Naccache
- Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France; Sorbonne Université, UPMC Université Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France
| | - A M Owen
- The Brain and Mind Institute and the Department of Physiology and Pharmacology, Western Interdisciplinary Research Building, N6A 5B7 University of Western Ontario, London, Ontario, Canada
| | - M Rosanova
- Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; Fondazione Europea per la Ricerca Biomedica Onlus, Milan 20063, Italy
| | - A O Rossetti
- Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - C Schnakers
- Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, CA, USA
| | - J D Sitt
- Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
| | - N D Schiff
- Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
| | - M Massimini
- IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy; Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy
| |
Collapse
|
2
|
Walk AM, Raine LB, Kramer AF, Cohen NJ, Khan NA, Hillman CH. Differential Effects of Carbohydrates on Behavioral and Neuroelectric Indices of Selective Attention in Preadolescent Children. Front Hum Neurosci 2017; 11:614. [PMID: 29326572 PMCID: PMC5742340 DOI: 10.3389/fnhum.2017.00614] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Accepted: 12/04/2017] [Indexed: 11/28/2022] Open
Abstract
The importance of breakfast consumption for ideal cognitive performance has received much attention in recent years, although research on the topic has yielded mixed results. The present study utilized event-related brain potentials (ERPs) elicited during a modified flanker task to investigate the neuroelectric implications of receiving different mixed macronutrient beverages after an overnight fast. A repeated measures design was employed whereby preadolescent participants (9–10 years of age) completed cognitive testing while ERPs were collected during two non-consecutive testing sessions, one in which they received one of three treatment beverages consisting of mixed-macronutrient formulations (either Carbohydrate Blend, Sucrose, Maltodextrin) and the other in which they received a placebo drink containing Sucralose. Performance indices, ERPs, and blood glucose were recorded at three time points before the testing session and after the ingestion of each drink. While the behavioral performance indices and N2 results showed some evidence of glucose facilitation, the effects were small and selective. Participants who received the Maltodextrin treatment showed faster reaction times and more stable N2 amplitudes after ingesting the treatment beverage. The most robust effects were seen in the P3 amplitude measurement. Across the three drink groups, participants showed a marked amplitude increase over time after the placebo drink was ingested, although P3 amplitudes remained stable when a carbohydrate treatment drink was ingested. These effects were eliminated when changes in blood glucose were accounted for, suggesting that the neurolectric effects were directly related to glycemic change. These findings suggest that ingestion of carbohydrates after an overnight fast results in changes to the P3 amplitude of the ERP waveform elicited during an attentional inhibition task.
Collapse
Affiliation(s)
- Anne M Walk
- Department of Kinesiology and Community Health, University of Illinois, Urbana-Champaign, Champaign, IL, United States
| | - Lauren B Raine
- Department of Psychology, Northeastern University, Boston, MA, United States
| | - Arthur F Kramer
- Department of Psychology, Northeastern University, Boston, MA, United States.,Beckman Institute, University of Illinois, Urbana-Champaign, Champaign, IL, United States
| | - Neal J Cohen
- Beckman Institute, University of Illinois, Urbana-Champaign, Champaign, IL, United States.,Department of Psychology, University of Illinois, Urbana-Champaign, Champaign, IL, United States.,Center for Learning, Nutrition, & Memory, University of Illinois, Urbana-Champaign, Champaign, IL, United States
| | - Naiman A Khan
- Department of Kinesiology and Community Health, University of Illinois, Urbana-Champaign, Champaign, IL, United States.,Division of Nutritional Sciences, University of Illinois, Urbana-Champaign, Champaign, IL, United States
| | - Charles H Hillman
- Department of Psychology, Northeastern University, Boston, MA, United States.,Department of Health Science, Northeastern University, Boston, MA, United States
| |
Collapse
|
3
|
Lechinger J, Wielek T, Blume C, Pichler G, Michitsch G, Donis J, Gruber W, Schabus M. Event-related EEG power modulations and phase connectivity indicate the focus of attention in an auditory own name paradigm. J Neurol 2016; 263:1530-43. [PMID: 27216625 PMCID: PMC4971049 DOI: 10.1007/s00415-016-8150-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2015] [Revised: 04/26/2016] [Accepted: 04/27/2016] [Indexed: 11/28/2022]
Abstract
Estimating cognitive abilities in patients suffering from Disorders of Consciousness remains challenging. One cognitive task to address this issue is the so-called own name paradigm, in which subjects are presented with first names including the own name. In the active condition, a specific target name has to be silently counted. We recorded EEG during this task in 24 healthy controls, 8 patients suffering from Unresponsive Wakefulness Syndrome (UWS) and 7 minimally conscious (MCS) patients. EEG was analysed with respect to amplitude as well as phase modulations and connectivity. Results showed that general reactivity in the delta, theta and alpha frequency (event-related de-synchronisation, ERS/ERD, and phase locking between trials and electrodes) toward auditory stimulation was higher in controls than in patients. In controls, delta ERS and lower alpha ERD indexed the focus of attention in both conditions, late theta ERS only in the active condition. Additionally, phase locking between trials and delta phase connectivity was highest for own names in the passive and targets in the active condition. In patients, clear stimulus-specific differences could not be detected. However, MCS patients could reliably be differentiated from UWS patients based on their general event-related delta and theta increase independent of the type of stimulus. In conclusion, the EEG signature of the active own name paradigm revealed instruction-following in healthy participants. On the other hand, DOC patients did not show clear stimulus-specific processing. General reactivity toward any auditory input, however, allowed for a reliable differentiation between MCS and UWS patients.
Collapse
Affiliation(s)
- Julia Lechinger
- Laboratory for Sleep and Consciousness Research, Department of Psychology, University of Salzburg, Hellbrunnerstraße 34, 5020, Salzburg, Austria.
- Centre for Cognitive Neuroscience (CCNS), University of Salzburg, Salzburg, Austria.
| | - Tomasz Wielek
- Laboratory for Sleep and Consciousness Research, Department of Psychology, University of Salzburg, Hellbrunnerstraße 34, 5020, Salzburg, Austria
| | - Christine Blume
- Laboratory for Sleep and Consciousness Research, Department of Psychology, University of Salzburg, Hellbrunnerstraße 34, 5020, Salzburg, Austria
- Centre for Cognitive Neuroscience (CCNS), University of Salzburg, Salzburg, Austria
| | - Gerald Pichler
- Apallic Care Unit, Neurological Division, Albert-Schweitzer-Klinik, Graz, Austria
| | - Gabriele Michitsch
- Apallic Care Unit, Neurological Division, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
| | - Johann Donis
- Apallic Care Unit, Neurological Division, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
| | - Walter Gruber
- Centre for Cognitive Neuroscience (CCNS), University of Salzburg, Salzburg, Austria
| | - Manuel Schabus
- Laboratory for Sleep and Consciousness Research, Department of Psychology, University of Salzburg, Hellbrunnerstraße 34, 5020, Salzburg, Austria
- Centre for Cognitive Neuroscience (CCNS), University of Salzburg, Salzburg, Austria
| |
Collapse
|
4
|
Leroy C, Bourriez JL, Dujardin K, Molaee-Ardekani B, Babiloni C, Deplanque D, Ponchel A, Hennion S, Plomhause L, Devanne H, Deguil J, Payoux P, Blin O, Méligne D, Micallef J, Chauveau N, Lanteaume L, Vervueren C, Guimont F, Thalamas C, Cassé-Perrot C, Rouby F, Bordet R, Derambure P. A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers. Clin Neurophysiol 2015; 130:863-875. [PMID: 26699666 DOI: 10.1016/j.clinph.2015.11.018] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2015] [Revised: 11/17/2015] [Accepted: 11/20/2015] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level. METHODS Thirty subjects were administered a daily dose of either 5mg donepezil or placebo for 15days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. RESULTS The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component. CONCLUSION Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil's effects in young, healthy, adult volunteers at a group level. SIGNIFICANCE Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer's disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.
Collapse
Affiliation(s)
- Christopher Leroy
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
| | - Jean-Louis Bourriez
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
| | - Kathy Dujardin
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Neurology and Movement Disorders, Lille University Medical Center, Lille, France
| | - Behnam Molaee-Ardekani
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
| | - Claudio Babiloni
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; Department of Neuroscience, IRCCS San Raffaele Pisana, Rome, Italy
| | - Dominique Deplanque
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France; CIC 1403 INSERM-CHU, Lille University Medical Center, Lille, France
| | - Amélie Ponchel
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France
| | - Sophie Hennion
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
| | - Lucie Plomhause
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
| | - Hervé Devanne
- Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France; ULCO, Calais, France
| | - Julie Deguil
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France
| | - Pierre Payoux
- INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France
| | - Olivier Blin
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Déborah Méligne
- INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France
| | - Joëlle Micallef
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Nicolas Chauveau
- INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France
| | - Laura Lanteaume
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Céline Vervueren
- INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France
| | - François Guimont
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Claire Thalamas
- Department of Medical Pharmacology, INSERM CIC 1436, Toulouse University Medical Center, Toulouse, France
| | - Catherine Cassé-Perrot
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Franck Rouby
- Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France
| | - Régis Bordet
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France
| | - Philippe Derambure
- INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
| | | |
Collapse
|
5
|
Tsolaki A, Kosmidou V, Hadjileontiadis L, Kompatsiaris I(Y, Tsolaki M. Brain source localization of MMN, P300 and N400: Aging and gender differences. Brain Res 2015; 1603:32-49. [DOI: 10.1016/j.brainres.2014.10.004] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2014] [Revised: 09/28/2014] [Accepted: 10/01/2014] [Indexed: 12/29/2022]
|